NYSE ARCA | ETF
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 6.12% |
| CELC | Celcuity LLC | Healthcare | Biotechnology | 5.86% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 5.41% |
| SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 5.07% |
| BAYN | Bayer AG NA | Healthcare | Drug Manufacturers - General | 5.05% |
| 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 4.52% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 4.47% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.47% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 4.37% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 4.36% |
| IPN | Ipsen SA | Healthcare | Drug Manufacturers - Specialty & Generic | 4.26% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 4.21% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 4.04% |
| 6160 | BeOne Medicines AG | Healthcare | Biotechnology | 4.04% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.99% |
| GSK | GlaxoSmithKline PLC | Healthcare | Drug Manufacturers - General | 3.95% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.87% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 3.86% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.83% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 3.61% |